Grant: Discovery Grants Program - Individual
Université Laval
$25,000.00
Phage peptide antibiotics
FY 2010-11
Summary
An understanding of bacterial cell division and development is fundamental in controlling bacteria infecting plants, animals and humans. A major difficulty in these studies is that inactivation of these essential genes gives a lethal phenotype. One of the novel approaches that we use is based upon the genetics of small single-stranded RNA or DNA phages that produce small peptides blocking and inhibiting Mur enzymes in bacterial cell wall synthesis. We will identify how these small peptides behave as antibiotics and characterize new genes controlling cell wall biosynthesis.
The alarming increase and spread of antibiotic resistance among bacterial pathogens is one of the most serious public health problems of the last decade. This critical situation necessitates the design of novel classes of antibacterial agents having new mechanism of action against novel targets. Nature could provide us with these new targets. Phages are viruses that are unique to and kill bacteria. Analysis of small phages and detailed studies of their unique lysis proteins will yield crucial information on how bacterial viruses inhibit and block bacterial cell wall synthesis. The study of the molecular mechanism of action of bacteriophage lysis proteins in a complete in vitro cell wall synthesis system developed by our laboratory is a relatively unexplored area. These studies will yield data and information about new mechanisms of action against novel antibacterial targets, namely the Mur cell wall biosynthesis proteins as well as small peptide antibiotics from phages.
Program
Discovery Grants Program - Individual
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
341729-2009
Name nom
Levesque, Roger
Department département
Biologie médicale
Organization id
51
Institution établissement
Université Laval
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2010
Competition year année de concours
2009
Award amount
25000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
32
Committee name en
Cell Biology
Committee name fr
Biologie cellulaire
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5201
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Bacteriology
Research subject fr
Bactériologie
Partie
2
Nb partie
5
Application title
Phage peptide antibiotics
Keyword
NSERC
Application summary
An understanding of bacterial cell division and development is fundamental in controlling bacteria infecting plants, animals and humans. A major difficulty in these studies is that inactivation of these essential genes gives a lethal phenotype. One of the novel approaches that we use is based upon the genetics of small single-stranded RNA or DNA phages that produce small peptides blocking and inhibiting Mur enzymes in bacterial cell wall synthesis. We will identify how these small peptides behave as antibiotics and characterize new genes controlling cell wall biosynthesis.
The alarming increase and spread of antibiotic resistance among bacterial pathogens is one of the most serious public health problems of the last decade. This critical situation necessitates the design of novel classes of antibacterial agents having new mechanism of action against novel targets. Nature could provide us with these new targets. Phages are viruses that are unique to and kill bacteria. Analysis of small phages and detailed studies of their unique lysis proteins will yield crucial information on how bacterial viruses inhibit and block bacterial cell wall synthesis. The study of the molecular mechanism of action of bacteriophage lysis proteins in a complete in vitro cell wall synthesis system developed by our laboratory is a relatively unexplored area. These studies will yield data and information about new mechanisms of action against novel antibacterial targets, namely the Mur cell wall biosynthesis proteins as well as small peptide antibiotics from phages.